Short answer
Ardent Health, Inc. (ARDT) filed its Q1 2026 10-Q quarterly report on May 6, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $1.6B (up 7.0% year over year) with net income of $40M.
Q1 2026 key financials · XBRL
- Revenue
- $1.6B
- +7.0% YoY
- Net income
- $40M
- −3.7% YoY
- EPS (diluted)
- $0.28
- −3.4% YoY
Source: XBRL data from the Ardent Health, Inc. (ARDT) Q1 2026 10-Q on SEC EDGAR. USD.
Ardent Health, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $104.6 million higher, up 7.0% YoY, driven by adjusted admissions up 2.0%
- Net patient service revenue per adjusted admission up 5.5% YoY
- Medicaid supplemental revenue $187.8 million vs $108.9 million YoY
- Adjusted admissions growth included surgeries up 1.2%, offset by admissions down 1.1%
- 2026 headwinds: lower Medicaid supplemental revenue expected, OBBBA impacts, expired ACA subsidies, labor costs
Risk Factors
- No material changes to previously disclosed risk factors from the Annual Report
- Stock repurchase authorization $50.0 million, with $46.8 million remaining at March 31, 2026
- Equity dilution risk from 119,521 shares withheld for restricted-stock-unit tax obligations
- No senior-security defaults reported during the quarter
- No new Rule 10b5-1 or non-Rule 10b5-1 trading arrangements adopted by directors or officers
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ardent Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.